The FDA announced a concerted action against direct-to-consumer (DTC) advertising of pharma products last September, and has since sent thousands of letters warning pharmaceutical and telehealth firms to remove misleading ads for a range of medicines, maintaining that the tally is more than were issued "over the entire preceding decade." The earlier letters also rapped Novo Nordisk and Lilly over advertising for their branded weight-loss medicines, Wegovy and Zepbound, which have been affected by low-cost competition from compounded versions
Bariatric surgery and obstructive sleep apnea: a systematic review and meta-analysis
This publication has not received compensated product samples for testing, has not interviewed Trimi or Arora Health personnel, has not been granted access to internal product specifications beyond what is publicly published, and has not conducted independent laboratory or clinical testing of any compounded medication
Traditional diets and weight loss methods often fail to address the root causes of obesity, leading to frustrating plateaus and disappointment
Store lyophilized KLOW in a freezer at -20C
ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway